Active Funding Opportunities and Notices for NICHD

NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.

NOTs and Active NOFOs for NICHD

Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.

Number Exp. Date Activity Code(s) Title
NOT-HD-23-037 January 1, 2027 Notice of NICHD Withdrawal from Participation in NOT-HL-23-117 "Notice of Special Interest (NOSI): Palliative Care in the Care Continuum among Persons with Serious Heart, Lung, Blood and Sleep (HLBS) Diseases and their Caregivers"
PA-23-317 November 24, 2026 332 Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
NOT-DC-24-010 November 6, 2026 R01 Notice of Special Interest (NOSI): Tackling Acquisition of Language in Kids (TALK) R01 Research Projects
NOT-OD-24-026 July 16, 2024 R21 Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21)
NOT-MH-24-125 January 1, 2027 Request for Information (RFI): BRAIN Initiative: Brain Behavior Quantification and Synchronization: Guidance for Opportunities in Development of Sensor Technology Hubs
NOT-NS-24-017 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
NOT-HD-23-034 January 1, 2027 Notice of Technical Assistance Webinar and FAQs for RFA-HD-24-007 (Understanding and Mitigating Health Disparities experienced by People with Disabilities caused by Ableism (R01 Clinical Trial Optional))
PAR-24-043 August 19, 2026 UG3/UH3 Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
RFA-HD-25-008 March 30, 2024 R61/R33 Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)
NOT-AA-23-020 November 30, 2026 333 Notice of Special Interest (NOSI): Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-23-189 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
PAR-24-063 August 19, 2026 U44 Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
RFA-NS-24-019 January 8, 2027 UG3/UH3 HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
PAR-23-294 November 19, 2026 R21 Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
PAR-23-293 November 19, 2026 R01 Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
PAR-23-295 November 17, 2026 R03 Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
PAR-24-046 November 20, 2024 R21 Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
NOT-HL-23-117 January 8, 2027 R01 Notice of Special Interest (NOSI): Palliative Care in the Care Continuum among Persons with Serious Heart, Lung, Blood and Sleep (HLBS) Diseases and their Caregivers
PAR-24-059 January 8, 2027 R01 Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional)
PAR-24-045 November 20, 2024 R21 Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
NOT-OD-24-002 January 1, 2027 Request for Information: Developing Consent Language for Research Using Digital Health Technologies
top of pageBACK TO TOP